From: The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients
Multivariate analysis
p
CYP3A5 (*1*1 or *1*3)
6.14 (0.61 - 66.8)
0.12
The initial trough concentration/starting dose > 1 ng/mL/mga
28.0 (3.20 - 631)
<0.0001